Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development KRMN Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Operational Challenges SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Progress PAG Q1 2026 Earnings EPS Beats Estimates Stock Rises Allbirds Q1 2026 Earnings Deeper Losses and Investor Caution Amid Restructuring HTB Q1 2026 Earnings EPS Surpasses Estimates by 1994 PCOR Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher Veris Residential Inc VRE Q4 2025 Earnings NarrowerThanExpected Loss Highlights Operational Discipline TGT Q1 2026 Earnings EPS of 171 Highlights Resilient Operations Amid Modest Stock Decline Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline Evercore Q1 2026 Earnings Blowout EPS Beats Estimates by 4665 FRMEP Q1 2026 Earnings Depositary Shares Deliver EPS Beat Driven by Solid Core Performance